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Abstract
AOC3 is highly expressed in adipocytes and smooth muscle cells, but its function in these cells is currently unknown. The in
vivo substrate(s) of AOC3 is/are also unknown, but could provide an invaluable clue to the enzyme’s function. Expression of
untagged, soluble human AOC3 in insect cells provides a relatively simple means of obtaining pure enzyme.
Characterization of enzyme indicates a 6% titer for the active site 2,4,5-trihydroxyphenylalanine quinone (TPQ) cofactor
and corrected kcat values as high as 7 s
21. Substrate kinetic profiling shows that the enzyme accepts a variety of primary
amines with different chemical features, including nonphysiological branched-chain and aliphatic amines, with measured
kcat/Km values between 10
2 and 10
4 M
21 s
21.K m(O2) approximates the partial pressure of oxygen found in the interstitial
space. Comparison of the properties of purified murine to human enzyme indicates kcat/Km values that are within 3 to 4-
fold, with the exception of methylamine and aminoacetone that are ca. 10-fold more active with human AOC3. With drug
development efforts investigating AOC3 as an anti-inflammatory target, these studies suggest that caution is called for
when screening the efficacy of inhibitors designed against human enzymes in non-transgenic mouse models. Differentiated
murine 3T3-L1 adipocytes show a uniform distribution of AOC3 on the cell surface and whole cell Km values that are
reasonably close to values measured using purified enzymes. The latter studies support a relevance of the kinetic
parameters measured with isolated AOC3 variants to adipocyte function. From our studies, a number of possible substrates
with relatively high kcat/Km have been discovered, including dopamine and cysteamine, which may implicate a role for
adipocyte AOC3 in insulin-signaling and fatty acid metabolism, respectively. Finally, the demonstrated AOC3 turnover of
primary amines that are non-native to human tissue suggests possible roles for the adipocyte enzyme in subcutaneous
bacterial infiltration and obesity.
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Introduction
Copper amine oxidases (CAOs) catalyze the oxidative deami-
nation of primary amines to form hydrogen peroxide, ammonia,
and the corresponding aldehyde, eq 1:
RCH2NH3
zzO2  ?
H2O
RCHOzNH4
zzH2O2 ð1Þ
These enzymes were first found to contain a novel redox cofactor,
the tyrosyl-derived topaquinone (TPQ) in the bovine serum amine
oxidase [1], with the distribution of TPQ now assigned to all living
aerobic organisms including bacteria, yeast, plants, and animals
with few exceptions such as the laboratory strain of Saccharomyces
cerevisiae. The susceptibility of TPQ to carbonyl reagents, such as
semicarbazide, has given rise to an alternate designation of
membrane-associated CAOs as a semicarbazide-sensitive amine
oxidase (SSAO) [2]. Efforts to elucidate the reaction mechanism of
CAOs have resulted in a consensus ping-pong mechanism during
which reducing equivalents from the amine substrate are stored in
an aminoquinol form of cofactor, which undergoes recycling to
TPQ concomitant with the conversion of O2 to H2O2 [3].
Though much is known about the enzymatic mechanism of
CAOs, the physiological role of mammalian enzymes is not well
understood, though it has been associated with several diseases.
Among the three TPQ-containing CAOs annotated in the human
genome (AOC1, 2 and 3), AOC3 has been implicated in
congestive heart failure [4], diabetes [5], Alzheimer’s [6], liver
disorders [7], and cancer [8]. An understanding of the
physiological role of AOC3, alternatively referred to as vascular
adhesion protein-1 (VAP-1), may provide a basis for treatment of
these diseases.
In bacteria and yeast, the CAOs are generally assumed to
catalyze the release of nitrogen and carbon from primary amines
for the support of microbial growth. Interestingly, CAOs are
among the most abundant soluble proteins found in the
extracellular fluids of pea, lentil, and chickpea seedlings and are
implicated in wound repair [9]. In mammals, the physiological
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xenobiotic and endogenously produced amines. However, the
natural substrate(s) of AOC3 in vivo is/are currently unknown and
kinetic data with purified enzyme have been sparse.
The distribution of AOC3 in mammalian tissues is wide-ranging
with relatively high expression shown in smooth muscle cells and
adipocytes [10]. In fact, it was found to contribute up to 2.3% of
total plasma membrane proteins in rat adipocytes [11]. To
complicate matters further, AOC3 is not only localized to the
extracellular surface of cells, known as membrane-bound AOC3,
but also exists as a soluble enzyme in plasma [12] and it is
unknown whether membrane-bound and plasma AOC3 have
similar physiological roles. Notably, endothelial AOC3 has been
implicated in the extravasation of leukocytes into inflamed tissue,
acting as an adhesion protein [13]. The process of extravasation
requires chemokines, cytokines, and an array of adhesion
molecules [14]. It has been shown that the enzymatic activity of
AOC3 is functionally important, impairing leukocyte recruitment
if activity is abolished either by inhibition or site-directed
mutagenesis [15]. Interestingly, a lectin, Siglec-10, expressed by
leukocytes was found to be a possible substrate of AOC3 and may
be involved in mediating adhesion [16], though the proposed
oxidation of an arginine side chain seems highly unlikely.
Currently, the precise mechanism of how AOC3 acts as a vascular
adhesion protein is unknown.
With the rise in worldwide rates of obesity, type-2 diabetes, and
metabolic syndrome X, interest in the biology of adipocytes has
increased, especially after the discovery of a class of more than fifty
adipose-derived cytokines, or adipokines [17]. Rather than
functioning as a passive organ primarily involved in fat storage,
insulation, and protection, adipose tissue is now thought to be
involved in a complex network of endocrine, paracrine, and
autocrine signals that influences the functions of many tissues [18].
AOC3 is not thought to function as an adhesion protein in
adipocytes and the function of this highly expressed, extracellular
enzyme is currently unknown.
Since adipose tissue plays an integral role in energy balance, a
possible role of adipocyte AOC3 could be an involvement in
insulin signaling. When rodents were administered AOC3
substrates such as methylamine, through dietary supplementation,
they showed improvement in glucose tolerance [19]. However, co-
administration of the non-physiological vanadate was required to
observe a pronounced effect, which can be rationalized by a
vanadate-dependent inhibition of tyrosine phosphatase or stimu-
lation of tyrosine protein kinases [20]. Interestingly, administration
of AOC3 substrate in the presence of catalase effectively abolished
the insulin-sensitizing effects, implicating an important role for
H2O2 [21]. Hydrogen peroxide has increasingly gained recogni-
tion as a possible cellular signaling molecule and is thought to play
a role in cell proliferation, differentiation, migration, and apoptosis
[22,23]. Specifically in adipocytes, H2O2 has been shown to be
involved in the activation of the insulin-signaling cascade [24]. It
has also been found that long-term exposure of obese rats to the
AOC3 inhibitor, semicarbazide, decreased fat deposition due most
likely to enhanced lipolysis, though decreased food intake was also
observed [25]. Though there may be a link between AOC3 and
insulin-signaling, there have been no other reports with regards to
how AOC3 may be involved in the insulin-signaling cascade and
the need for vanadate to produce a pronounced effect makes this
link somewhat tenuous.
With an interest in understanding the physiological function of
AOC3 in adipocytes, we have focused on characterizing the
suitability of various amine substrates, including primary amines
annotated in the Human Metabolome database [26], for turnover
by measuring kinetic parameters using the cloned human AOC3
expressed and purified from insect cells. Since animal studies most
often use mouse models, a comparison of human to mouse enzyme
is also reported. Finally, differentiation of murine-derived
fibroblasts to adipocytes permits a comparison of purified enzyme
to cell-associated AOC3. Based on the resulting profile of substrate
specificity, a number of formerly unrecognized substrates and
possible biological functions emerge.
Materials and Methods
All chemicals, reagents, and column chromatographic resins,
including AOC3 substrates, were purchased from Sigma Aldrich
(St. Louis, MO) unless otherwise stated. Aminoacetone was
purchased from Tyger Scientific, Inc. (Ewing, NJ). [1,1-
2H2]Ben-
zylamine hydrochloride was prepared as previously described [27].
The purity of synthesized [1,1-
2H2]benzylamine hydrochloride
was verified by NMR with no evidence of contamination by the
protium substrate or other chemical contaminants. Peptide-bound
lysine (GGGGKGGGG) was synthesized by the Stanford
University Protein and Nucleic Acid Facility (PAN). Calcium
phosphate transfection kit was purchased from Invitrogen
(Carlsbad, CA). DMEM High Glucose, purchased from GIBCO
(Carlsbad, CA) was used in the course of culturing adipocytes. Gel
filtration column chromatographic resin, Sephacryl S-200 HR,
was purchased from Amersham Biosciences (Piscataway, NJ).
Cell Culture
s2 Drosophila cells were purchased from Invitrogen (Carlsbad,
CA) and grown in BioWhittaker Insect-XPRESS insect cell media
from Lonza (Walkersville, MD) at 27uC. For antibiotic selection,
s2 media was supplemented with 600 ug/mL hygromycin
purchased from Invitrogen (Carlsbad, CA). Murine 3T3-L1
preadipocytes were obtained from the American Type Cell
Culture (Bethesda, MD). The adipocyte differentiation protocol
starts with a 100 mm tissue culture dish of 3T3-L1 preadipocytes
grown to confluence. Once confluent, cellular differentiation was
induced using insulin, dexamethasone, and methylisobutyl-
xanthine as previously described [28]. Cells were cultured in
Dulbecco’s Modified Eagle Medium (DMEM) supplemented with
10% fetal bovine serum (FBS) purchased from Hyclone (Waltham,
MA). Only passage 1 or 2 adipocytes were used at Days 8 to 10
post-differentiation. Adipocytes were maintained at 37uC and 5%
CO2.
Construction of Expression Vector for Producing Soluble
Human and Murine AOC3
The soluble portion of human AOC3 (GenBank Accession
No. NM_003734) from residues 28 to 763 was cloned by PCR
from a VAP-1 (vascular adhesion protein-1, AOC3) cDNA-clone
plasmid (generously provided by Prof. Sirpa Jalkanen) containing
the complete coding sequence of human AOC3. Amplification
was performed using the 59 primer 59-TATCAGGAATTC
ATGCAGGGGTGGAGATGGGGGTGA-39 with EcoRI re-
striction site introduced upstream of the N-terminus. The 39
primer was 59-TATCAG CTCGAGTTACTAGTTGTGAGA-
GAAGCCCCCGTG-39 with XhoI restriction site introduced
after two stop codons. PCR was carried out for 30 cycles with
1 min denaturing at 95uC, 1 min annealing at 60uC, and 2 min
15 sec elongation at 72uC. The PCR product was ligated into the
s2 expression vector pMT/BiP/V5-His B from Invitrogen
(Carlsbad, CA). The extra 17 amino acids at the N-terminus of
recombinant human AOC3 was due to the restriction enzymes
used. Upstream restriction enzymes were not used due to the
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generously provided by Prof. Sirpa Jalkanen), a construct was
created in a manner similar to the human AOC3 in which the first
27 amino acids corresponding to the membrane anchor were
removed. PCR was carried out on the full-length AOC3 sequence
with the following primers: 59 primer 59-GTGGAATTCATGGG-
CAGGAGCGGAGATG-39 and 39 primer, 59-ATATCTAGA-
TACAGTT CAATTGTCTCTGTAAGCAAAG-39. The trun-
cated sequence was inserted into the pMT/BIP/V5-His B vector
using the EcoRI and XbaI restriction sites.
Transfection of Schneider 2 (s2) Drosophila Cells and
Selection of Stable Cell Line
s2 cells were grown to 2 to 4610
6 cells/mL in serum-free insect
cell media and co-transfected with pMT/BiP/V5-His B-human
AOC3 plasmid and pCoHygro selection vector using calcium
phosphate. The suggested transfection procedure provided by the
manufacturer was followed except calcium chloride and phosphate
solutions were added 10 uL at a time with ample mixing. Two
days post-transfection, s2 cells were washed twice and resuspended
in cell media supplemented with 10% FBS and 300 ug/mL
hygromycin. The s2/hygromycin kill curve was determined
indicating that a minimum dose of 600 ug/mL hygromycin was
required to kill all untransfected cells. After one week, antibiotic
dose was increased to 600 ug/mL hygromycin and selection
continued for two more weeks. Amine oxidase activity was not
detectable in small-scale test expressions of 50 to 100 mL. Samples
showing a band around 90 kDa on SDS-PAGE gel were scaled up
to 500 mL total volume and eluted from an ion exchange column
prior to assaying for activity (see below). Transfection with the
murine AOC3 plasmid used protocols similar to those for human
AOC3.
Western Blot Analysis
Samples were run on 10% acrylamide, denaturing SDS-PAGE
gel using a Laemmli buffering system and transferred to
nitrocellulose membrane. Blocking was performed for 1 h at
room temperature. After washing three times, membrane was
incubated with a 1:2400 dilution of primary anti-human or murine
AOC3 antibody (generously provided by Prof. Sirpa Jalkanen) in
blocking buffer with gentle agitation for approximately 14 to 16 h
at 4uC. Membrane was then washed three times and incubated in
1:1000 dilution of secondary antibody, horseradish peroxidase
conjugated anti-mouse Ig from Cell Signaling Technology
(Danvers, MA) with gentle agitation for 1 h at room temperature.
The membrane was immediately developed using ECL Plus
Western Blotting Detection System from GE Healthcare, (Buck-
inghamshire, UK).
Purification of Human AOC3
All steps of purification were performed at 4uC and were
initiated immediately post-expression. Starting with 1.5 L raw
expression media, the s2 cells were spun down at 4000 rpm for
15 min. The supernatant was isolated and concentrated to
approximately 750 mL. The concentrated media was then
dialyzed in 12 L of 10 mM potassium phosphate (KPi) buffer,
pH 6.5 for at least 4 h, after which buffer was replaced and dialysis
allowed to continue for approximately 15 h more. The first
purification step involved cation exchange chromatography using
75 mL of SP Sepharose Fast Flow equilibrated with 10 mM KPi,
pH 6.5. The dialyzed media was filtered (0.22 um) and loaded
onto the cation exchange column and eluted off the column with
1 L buffer step gradient (500 mL 10 mM KPi pH 6.5 and 500 mL
10 mM KPi pH 6.5/250 mM NaCl) into fractions by gravity. The
fractions were analyzed on a SDS-PAGE gel and those containing
AOC3 were collected and pooled. The pooled fractions were
concentrated to approximately 10 mL and diluted with 10 mL
10 mM KPi buffer, pH 6.5, 20% glycerol to make a final 20 mL
10% glycerol solution to help stabilize the protein and minimize
precipitation. The glycerol did not affect enzyme activity when
compared to activity of enzyme purified without addition of
glycerol. The 20 mL partially purified protein was further
concentrated down to 1 to 2 mL. The concentrate was centrifuged
and the soluble portion loaded onto a gel filtration column,
charged with 290 mL Sephacryl S-200 HR equilibrated with
50 mM KPi, pH 6.5. A pump was connected to the gel filtration
column with flow regulator, collecting 1 mL fractions over 16 to
20 min. Fractions were run on a SDS-PAGE gel and those
indicating purified AOC3 were collected and concentrated to
approximately 50 to 200 uL. Benzylamine oxidase activity was
measured. The benzylamine substrate was dissolved in 50 mM
KPi, pH 6.5 at a concentration of 2 mM. Buffer with benzylamine
was blanked in a Cary 50 Bio UV-Vis spectrophotometer from
Varian (Palo Alto, CA) before addition of either 3 uL or 6 uL
purified AOC3 to initiate reaction at room temperature and total
volume of 110 uL. Benzaldehyde product formation was moni-
tored at absorbance l=250 nm (e=13800 M
21 cm
21 [29]) for
1 min. Purified protein was immediately snap-frozen in 50 mM
KPi, pH 6.5 buffer with liquid nitrogen and stored at 220uC. The
purification of murine AOC3 was performed in a similar manner
to human AOC3, with minor modifications. Murine AOC3 was
purified using anion exchange resin, DEAE Sepharose Fast Flow
from Amersham Biosciences (Piscataway, NJ), equilibrated with
5 mM KPi, pH 7.2, eluting with two 1 L buffer gradients
composed of either equal volumes of 5 mM KPi, pH 7.2 and
100 mM KPi, pH 7.2 or 100 mM KPi, pH 7.2 and 300 mM KPi,
pH 7.2. Enzyme mostly eluted off the anion exchange column
after the 5 mM/100 mM gradient. Gel filtration conditions were
similar, though collected protein was loaded onto the same column
2 to 3 times.
Determination of TPQ Content
The TPQ content of AOC3 was determined using phenylhy-
drazine in 50 mM KPi, pH 6.5 [30], at room temperature by
measurement of the change in absorbance at l=448 nm with and
without phenylhydrazine using e=40500 M
21 cm
21. This ex-
tinction coefficient was determined for copper amine oxidase
expressed by the yeast, Hansenula polymorpha (cf. [3]). The
concentration of enzyme monomer was determined by Bradford
assay using reagents from Biorad (Hercules, CA) using bovine
albumin, fraction V from Pierce (Rockford, IL) standard and MW
per monomer of 84622.
ICP
Copper and zinc standards were made through serial dilutions
from reference solutions from Fisher Scientific (Pittsburgh, PA).
ICP was performed on a Perkin Elmer Optima 7000 (Waltham,
MA).
Kinetic Characterization of AOC3
Steady-state kinetic measurements were carried out by moni-
toring oxygen consumption using a Clark electrode and YSI
Model 5300 Biological Oxygen Monitor. In the case of human
AOC3, a final volume of 1 ml contained 500 mM KPi, pH 7.4 at
37uC, to which variable amounts of substrate were added; reaction
was initiated by addition of AOC3. For the screening of murine
AOC3, the conditions were similar to human AOC3, although the
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PLoS ONE | www.plosone.org 3 January 2012 | Volume 7 | Issue 1 | e29270concentration of buffer was only 50 mM. Unless otherwise noted,
the oxygen concentration was kept constant at 211 mM. Data were
fitted to the Michaelis-Menten equation, and kcat was calculated
using the active protein concentration as determined by
phenylhydrazine assay described above.
Microscopic Examination of the Subcellular Localization
of Murine AOC3
3T3-L1 preadipocytes were grown and differentiated on glass
coverslips coated with poly-L-lysine (MW=100K–150K). On day
5 post-differentiation, cell media was replaced with fresh DMEM
containing 10% FBS. Cells were refrigerated prior to use. Mature
adipocytes on coverslips were prepared for immunofluorescence
by washing twice with PBS. Cells were fixed by incubating with
4% paraformaldehyde for 10 min [31]. After blocking, cells were
incubated with a monoclonal primary anti-mouse AOC3 antibody
followed by the secondary anti-rat Ig antibody [32]. After washing
with phosphate-buffered saline (PBS), cells were mounted using
Prolong Kit from Molecular Probes (Carlsbad, CA). Cells were
allowed to sit overnight before evaluation by confocal microscopy.
Whole Cell Assay of Murine AOC3 Activities
Murine 3T3-L1 adipocytes were cultured in 24-well plates.
Prior to the experiment, cells were washed twice with warmed PBS
and once with warmed DMEM+10% FBS. Only wells fully
populated by differentiated adipocytes (at least 90% of cell
population) were used. For measurements involving isoamylamine
substrate, adipocytes were incubated in 500 uL DMEM+10% FBS
and all cells treated with 0.33 mM clorgyline and 3.33 mM L-
deprenyl to eliminate activity of monoamine oxidase from
measurements [33]. In the set of control experiments, adipocytes
were also treated with 1 mM AOC3 inhibitor, semicarbazide.
Cells were incubated with inhibitors for 30 min at 37uC and 5%
CO2. After incubation, cells were washed twice with warmed
Krebs Ringer Phosphate (KRP) (145 mM NaCl, 5.7 mM sodium
phosphate, 4.86 mM KCl, 0.54 mM CaCl2, 1.22 mM MgSO4,
5.5 mM glucose, pH 7.35) buffer. A coupled enzymatic reaction
involving horseradish peroxidase (HRP) and Amplex Red
purchased from Molecular Probes (Carlsbad, CA) was used to
detect H2O2 production resulting from substrate turnover. Upon
final addition of 500 uL KRP buffer containing 50 uM Amplex
Red reagent and 0.1 U/mL HRP, isoamylamine (from 125 uM to
8 mM) was added to wells pre-incubated either with or without
inhibitor. All procedures involving Amplex Red were performed in
the dark. Envision Multilabel Reader with a 570 nm optical filter
from Perkin Elmer (Waltham, MA) was used to determine the
absorbance of oxidized Amplex Red. Measurements were taken
every 3 min for 30 min at 37uC. Endpoint absorbance changes
were used to determine kinetic rate and to calculate the whole cell
Km of isoamylamine.
For measurements involving aminoacetone and methylamine,
mature adipocytes were washed twice with room temperature
phosphate buffered saline followed by incubation in 1 ml Krebs
Ringer phosphate glucose solution for 30 min. One unit (1 U) of
horseradish peroxidase and 50 ng of Amplex Red dye were added
to each well. After mixing, the plate was incubated at 37uCi na
fluorescence plate reader (Gemini System using the Softmax
software package) and a background rate for Amplex Red
oxidation was measured (lEx=560 nm and lEm=590 nm).
Aminoacetone or methylamine was then added and the rate of
Amplex Red oxidation was determined by subtracting the
background from the rate obtained after substrate addition. Both
direct (slope) and endpoint fluorescence changes were measured
and the determined rates were used to calculate an averaged Km
value.
Results
Untagged, Recombinant Human AOC3
Previous recombinant forms of human AOC3 have been
purified via conjugation of a modified GST tag to the N-terminus
of the soluble enzyme and the concomitant use of glutathione-
affinity chromatography [34], immunoaffinity chromatography
using a N-terminal FLAG epitope [35], or a one-step purification
using commercially unavailable anti-AOC3 monoclonal antibody
[36]. Herein, a purification procedure of the untagged soluble
human AOC3 enzyme was developed. Attempts to express
recombinant AOC3 in E. coli and S. cerevisiae were unsuccessful.
Expression proved viable in s2 Drosophila cells, consistent with the
earlier report by Dooley and co-workers of the overexpression of
human kidney diamine oxidase (AOC1) in the s2 insect cell line
[37].
In this study, the soluble portion of human AOC3 was cloned
into an expression plasmid containing an upstream-inducible
metallothionine promoter and BiP secretion signal and stably
transfected into s2 Drosophila cells, resulting in secretion of the
enzyme into cell media upon induction. An immunoblot of
fractions from the ion exchange chromatograph resulted in a
significant band at approximately 90 to 100 kDa, the expected size
of the monomer of soluble AOC3 calculated as 84 kDa in the
absence of posttranslational modification, Fig. 1A. Subsequent
purification of the eluant from cation exchange by gel filtration
chromatography resulted in pure enzyme, as shown in Fig. 1B.
The yield of enzyme varied from 160 to 480 ug/L of purified
enzyme. The transfection of s2 cell lines using calcium phosphate
after selection has been reported to result in up to 500 copies of
inserted genes with expression of up to 50 mg/L of recombinant
human enzymes reported [38,39]. The relatively low yield of
AOC3 is attributed to poor transfection efficiency. Nonetheless,
the yield of AOC3 obtained in this manner is comparable to that
from other expression procedures, with the advantages of
untagged protein and easily accessible purification steps. The
uncorrected specific activity (see below) was approximately
46 nmol/min/mg of monomer.
Characterization of Purified Human AOC3
Observed rates were linear in enzyme concentration and
eliminated by prior incubation of purified enzyme with 100 uM
semicarbazide inhibitor for 5 min. The quinone moiety of the
AOC3 active site cofactor, TPQ, can be derivatized using the
carbonyl reagent phenylhydrazine to yield the resulting hydrazone
product, which can be monitored at 448 nm. The percent of
active protein determined in this manner was approximately 6.1%,
Table 1, leading to a corrected specific activity of ca. 0.76 mmol/
min/mg of monomer under the conditions of the standard assay.
Since the biogenesis of TPQ requires copper [40], spiking purified
enzyme with sub-stoichiometric amounts of CuCl2 could increase
the percent of active protein. However, the specific activity
actually decreased with precipitation observed (data not shown).
The copper content was determined by ICP and found to be 0.4
moles per mole of AOC3 monomer. The copper content is
surprisingly low, given that s2 cells were induced to express AOC3
with 600 uM CuSO4. Additionally, the zinc content was found to
be 0.16 moles per mole of AOC3 monomer. Zinc-substituted
bovine serum amine oxidase has been found to be catalytically
inert [41], with tighter binding of the apo-enzyme for zinc than
copper shown in the yeast H. polymorpha amine oxidase [42]. The
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2+-reconstituted enzyme is due to the requirement
for a redox active metal during TPQ biogenesis [43]. In light of
only 40% of the total protein subunits containing copper, the
efficiency of post-translational cofactor biogenesis is estimated as
15%.
Steady-State Substrate Kinetic Profiling of Human AOC3
Most kinetic measurements of AOC3 have relied on the use of
cell lysates or membranes, rather than pure enzyme, and
colorimetric reagents, such as Amplex Red, to measure hydrogen
peroxide production [44]. This approach requires the determina-
tion of any sub-cellular background reaction rate following the
introduction of an AOC3 inhibitor. In addition, interaction of
AOC3 with cellular components could affect enzyme activity.
Rather than measure hydrogen peroxide production, O2
consumption was monitored directly using a Clark oxygen
electrode. A high ionic strength (500 mM potassium phosphate
buffer) was maintained so that the assay of all substrates (including
those with elevated Km values) could be carried out at the same
final ionic strength. Comparison of steady-state kinetic rates of
benzylamine oxidation with results from kinetic assays at lower
ionic strength (50 mM potassium phosphate buffer) did not show a
significant difference, indicating little impact on rate due to the
higher ionic strength for this substrate. Addition of 10 to 150 mM
NaCl to kinetic assays of human copper amine oxidase activity has
previously been found to have little effect on the rate-determining
step [44]. Using the purified AOC3 and our O2 uptake assay, a
variety of aryl-, straight chain alkyl-, and branched chain
alkylamines, including several amines in the Human Metabolome
database [26], were examined for activity with measured values of
kcat and Km in Table 2.
Both methylamine and ethylamine are found endogenously in
mammals [45,46]. However, when comparing kcat and Km of
straight-chain alkylamines, no apparent trend in kcat and Km is
observed as the alkyl chain is lengthened (1 to 5 carbons). In an
earlier study, a decrease in Vmax and increase in Vmax/Km were
reported with an increase in chain size (up to 9 carbons) using
AOC3 derived from human-solubilized adipocyte membranes
[44]. Km values are all observed to be in the mM range with the
exception of methylamine (652 uM), that still contrasts markedly
with human plasma levels of methylamine found to be on average
31.8 ng/mL (1.03 uM) [47]. Branched chain amines are not
thought to occur endogenously, but both isobutylamine and
isoamylamine are reasonably good substrates with mM Km values.
On the other hand, isopropylamine was not found to have any
AOC3 activity. Substrates of human AOC3 also include
arylamines and catecholamines, with the non-physiologic benzy-
lamine exhibiting a low Km value (84.5 uM) and the highest kcat/
Km. Adding an extra methyl group to benzylamine results in an
Table 1. Properties of purified human AOC3.
Property Value
TPQ content
a 0.06
Copper content
a 0.4
Km (O2)2 8 64.6 torr 3864.2 uM
kcat(H)/kcat(D)
b 1.2360.08
[kcat/Km(S)]H/[kcat/Km(S)]D
b 8.6462.82
aPer monomer.
bAt ambient O2, pH 7.4, 37uC.
doi:10.1371/journal.pone.0029270.t001
Table 2. Human AOC3 substrate kinetic profile.
Substrate kcat(s
21)K m(uM) kcat/Km(M
21 s
21)
Methylamine
a 5.6060.20 652677 8.5860.12610
3
Ethylamine
a 6.1260.40 1280061960 4.7860.17610
2
Propylamine 5.8060.23 26506260 2.1960.10610
3
Butylamine 6.3160.31 28306460 2.2360.17610
3
Amylamine 4.3360.19 57106760 7.5760.14610
2
Isobutylamine 7.4060.51 34206540 2.1660.17610
3
Isoamylamine 6.8960.83 456061160 1.5160.28610
3
Benzylamine 3.4260.10 84.569.8 4.0560.12610
4
Phenethylamine
a 1.1260.08 20506620 5.4560.31610
2
Cyclohexanemethylamine 5.3660.77 1650065200 3.2560.35610
2
Dopamine
a 0.5460.033 99624 5.4460.25610
3
Aminoacetone
a 1.4660.10 66618 2.2360.28610
4
Cysteamine
a,b 1.1160.14 31615 3.5560.50610
4
aSubstrates of human AOC3 with entries found in the Human Metabolome
Database version 2.5.
bSubstrate kinetics were measured at approximately 19 to 23% air (4 to 5% O2).
doi:10.1371/journal.pone.0029270.t002
Figure 1. Purification of human AOC3 expressed by s2
Drosophila cells. A. Immunoblot of fractions obtained after ion
exchange column chromatography, showing human AOC3 at the
expected mass. Protein ladder to the left of Lane 1 (top band, blue
2100 kDa; bottom band, red 275 kDa). B. 10% acrylamide, denaturing
SDS-PAGE gel electrophoresis of fractions using a Laemmli buffering
system after gel filtration column chromatography. Fractions repre-
sented in lanes 4 to 8 and 10 were isolated and concentrated for further
characterization. Protein ladder shown in Lane 9 (second band from top
2116 kDa, third band 297 kDa, fourth band 266 kDa). Approximately
0.25–2 ug of protein was loaded into each lane.
doi:10.1371/journal.pone.0029270.g001
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approximately two orders of magnitude, indicating that the
endogenous phenethylamine [48] is an unlikely substrate.
Catecholamines were observed to consume oxygen under
ambient air prior to addition of enzyme. However, lower
concentrations of dopamine, epinephrine, and norepinephrine
(below 1.2 mM) allowed measurement of steady-state kinetics,
without a high background rate of oxygen consumption masking
the rate of amine oxidation by AOC3. Dopamine was found to
have a Km of approximately 99 uM, which is about 12-fold less
than the maximum substrate concentration used, allowing a
reasonable estimate of kcat. Dopamine has a demonstrated role in
adipocyte metabolism, binding to the b3-adrenoreceptor, resulting
in lower glucose uptake [49]; in this context, AOC3 oxidation of
dopamine may moderate ligand/receptor interactions. Neither
norepinephrine nor epinephrine (a secondary amine), exhibited
any reproducible AOC3 activity above background and other
endogenous amines, such as tyramine, tryptamine, histamine, and
octopamine were found to have either little or no AOC3 activity.
Aminoacetone, a threonine and glycine metabolite [50], and
cysteamine, a breakdown product of pantethine (a coenzyme A
precursor) [51], are both found in humans and were found to have
among the lowest Km values (66 uM and 31 uM, respectively), as
well as relatively high second order rate constants. Both substrates
can auto-oxidize in ambient air with cysteamine assays yielding a
high background rate of oxygen consumption at all concentrations
of amine tested. Thus, to characterize the steady-state kinetics of
cysteamine oxidation, it was necessary to reduce the oxygen
concentration to 19 to 23% air. This is around the Km(O2)o f
human AOC3, which was found to be approximately 2864.6 torr
(18% air) (Table 1), close to the partial pressure of oxygen in the
interstitial space of tissue (ca. 20 to 40 torr [52]). While reduction
in the O2 concentration is expected, thus, to reduce kcat ca. 2-fold,
it will not influence the comparative kcat/Km value. The second
order rate constants, kcat/Km, were within two orders of
magnitude for all of the amines examined, 10
2 to 10
4 M
21 s
21.
The kinetic isotope effect (KIE) of amine oxidation was
evaluated using benzylamine with both hydrogens at the a carbon
replaced with deuterium (Table 1). The isotope effects were found
to be 1.2360.08 at substrate saturation and 8.6462.82 at low
substrate (below Km). This indicates that steps leading up to and
including the base-catalyzed proton abstraction from substrate are
not rate-limiting at substrate saturation, whereas the C–H
cleavage step becomes rate-determining at low substrate concen-
trations. This result can be of assistance in evaluating the impact of
variations in substrate structure on catalytic efficiency (see next
section below and ref [53]). After the completion of this work,
Heuts et al. published similar results for the isotope effect using
benzylamine, with additional studies using phenethylamine and its
para-substituted compounds [54]. Interestingly, they show a high
KIE on kcat for phenethylamine, indicating that for a slightly larger
substrate, proton abstraction becomes rate-limiting under condi-
tions of saturation by substrate and O2.
The mechanism of vascular adhesion by leukocytes to AOC3-
expressing endothelial cells has been hypothesized to proceed via
the interaction of a peptide-bound lysine on the extracellular
surface of leukocytes with AOC3 [55]. This could involve either
simple binding/inhibition or oxidation of the lysyl e-amino group.
In this study, neither L-lysine (minimal activity at 38 mM) nor D-
lysine was found to have appreciable AOC3 activity. Similar
results were shown by previous kinetic studies using bovine AOC3,
though L-lysine has been shown to act as an AOC3 inhibitor, but
only in the presence of benzylamine [56]. In addition, the small
lysine containing peptide, GGGGKGGGG, which has been
shown to be an AOC3 inhibitor [57], was found to be inactive
toward AOC3 as a substrate at concentrations up to 38 mM. The
ability of a protein-bound lysine to serve as the in vivo substrate for
AOC3 seems unlikely, though a sequence-dependent activity
cannot be ruled out.
Comparing previous data obtained from cell lysates containing
AOC3 to the present results, [58], the Km of methylamine was
found to be 670 uM versus our finding of 652 uM and the Km of
phenethylamine was found to be 1940 uM versus our finding of
2050 uM. The Km of benzylamine, determined with crude
membranes from human adipose tissue [59], was found to be
175 uM versus our finding of 84.5 uM. Since the earlier data did
not rely on purified enzyme, Vmax values were reported in rate per
mg of cell lysate, precluding quantification of kcat values.
Comparison of Human and Mouse AOC3 Substrate
Kinetics
The implication of AOC3 in inflammatory disorders has made
the search for small molecule inhibitors an active area of research
[60]. In order to assess drug efficacy and safety, it is expected that
initial trials will occur in mouse subjects. Though human and
mouse AOC3 are 83% identical and 91% similar (Fig. S1),
differences in the enzymatic activity may arise. To investigate
these kinetic differences, the mouse AOC3 was expressed and
purified as described for human AOC3 with modifications (see
Experimental Procedures), and steady-state kinetics performed
using a Clark O2 electrode. We chose to focus comparisons on the
parameter kcat/Km (Table 3), since the deuterium isotope effects
for the human AOC3 (Table 1) indicate that this is the parameter
that will be sensitive to substrate structure. We note that,
analogous to human AOC3, no activity was observed with either
free lysine or the lysine containing GGGGKGGGG. In the case of
the methyl ester of lysine, kcat/Km was ca. 12 M
21 s
21. It can be
seen that for the majority of substrates examined, kcat/Km varies
within approximately one order of magnitude and rates are within
a factor of 3 to 4 times of one another. For alkylamines, as the
chain length increased, the enzymatic efficiency of human AOC3
decreases relative to the mouse enzyme, though the human
enzyme is better at catalytic turnover until amylamine. For
branched chained amines, the mouse enzyme was found to be
more efficient; in the case of isopropylamine, neither the human
Table 3. Comparison of second order rate constants (kcat/Km)
between purified human and mouse AOC3.
Substrate Human
a Mouse
a Human/Mouse
Methylamine 8.58 0.730 11.8
Ethylamine 0.478 0.109 4.4
Propylamine 2.19 0.722 3.0
Butylamine 2.23 1.41 1.6
Amylamine 0.757 1.39 0.55
Isobutyamine 2.16 2.27 0.95
Isoamylamine 1.51 4.91 0.31
Benzylamine 40.5 12.9 3.2
Phenethylamine 0.545 0.955 0.57
Aminoacetone 22.3 2.94 7.6
Dopamine 5.44 18.3 0.3
akcat/Km (M
21 s
21)610
3 for human and mouse AOC3.
doi:10.1371/journal.pone.0029270.t003
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differences are the substrates, methylamine and aminoacetone,
that appear 10 to 12 times more active with the human AOC3.
These results suggest that caution is called for when screening the
efficacy of inhibitors designed against human enzymes in non-
transgenic mouse models during pre-clinical analysis. In addition,
the expected differences in tissue levels of AOC3 substrates in
human versus mouse (see below) could greatly impact the
experimental output. Future modeling studies will address
structural origins of kinetic parameter differences between the
murine and human enzymes, Table 3.
Murine 3T3-L1 Adipocytes Express Active Extracellular
AOC3
AOC3 expression has been shown on the extracellular surface
of adipose tissue in laboratory mice [61]. In addition, AOC3,
present in intracellular vesicles of endothelial cells under normal
conditions, is transported to the surface during inflammation, at
which point AOC3 becomes a membrane-bound ecto-enzyme
[12]. Analogous experiments are necessary in cultured 3T3-L1
adipocytes, to validate in vitro assays. AOC3 has been found to be
absent in undifferentiated Day 0 3T3-L1 pre-adipocytes and
abundant in Day 8 mature lipid-laden adipocytes [62]. In
addition, AOC3 activity is thought to ameliorate insulin resistance
and is implicated in insulin signaling [20,21]. If AOC3 plays an
important role in insulin signaling, it is possible that the enzyme
may co-localize with the insulin receptor, which is purportedly
found in lipid raft domains prevalent in adipocytes and known as
caveolae [63]. However, the localization of AOC3 expression is
found to be uniform, covering the extracellular surface of Day 9
adipocytes as shown by immunofluorescence in Fig. 2A, making
co-localization unlikely, at least under ex vivo cell culture
conditions. AOC3 expression was not prevalent until Day 5
during the differentiation process and continued to increase at Day
12 as shown by the immunoblot in Fig. 2B. Plasma membrane
AOC3 is abundant on the extracellular surface of mature 3T3-L1
adipocytes, though entirely absent in pre-adipocytes.
With experimental verification of the extracellular expression
of AOC3 by 3T3-L1 adipocytes, we moved to an examination of
the enzyme in its cellular context. Agreement between purified
enzyme and whole cells would support the utilization of data
from isolated enzyme in making conjectures regarding possible in
vivo substrates. Kinetic analyses were performed using Amplex
Red dye, since direct oxygen uptake assays were expected to be
complicated by other cellular processes. Figure 3 shows the time
concentration dependence of extracellular H2O2 production
with methylamine as substrate, demonstrating a linear increase
in peroxide production that is dependent on varying substrate
concentrations. In Table 4, Km values are summarized with no
effort in the present study to obtain the total AOC3
concentration on the surface of adipocytes as a prerequisite for
kcat. The Km values are within 1.5 to 4.2-fold of values
determined with purified murine AOC3. Further, the Km values
for methylamine and aminoacetone with human AOC3 lie
between the Km values determined with either the purified
murine enzyme or murine-derived adipocytes. The obvious
outlier in Table 4 is the 10-fold larger Km for isoamylamine
toward purified human enzyme in relation to murine adipocyte-
associated AOC3. The rate of hydrogen peroxide production by
the murine 3T3-L1 adipocytes in the presence of 750 uM
isoamylamine was quantified to be ca. 11 uM/h per million cells,
a level that has been shown to induce oxidative stress signaling in
mammalian cells [64].
Figure 2. Visualization of AOC3 during murine 3T3-L1 adipo-
cyte differentiation. A. Use of confocal fluorescence microscopy. Top,
phase contrast image of adipocytes; bottom, overlay of immunofluo-
rescence with phase contrast image (Anti-mouse AOC3 antibody
courtesy of Sirpa Jalkanen). B. Differentiation, as detected by Western
blotting using anti-mouse AOC3 antibody.
doi:10.1371/journal.pone.0029270.g002
Figure 3. Adipocyte cell culture-based determination of AOC3
turnover in the presence of varying concentrations of methyl-
amine substrate using the Amplex Red peroxide detection
assay.
doi:10.1371/journal.pone.0029270.g003
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A very puzzling finding - that the identical CAO (designated
AOC3) appears on the outer plasma membrane of both human
endothelial tissue and the human adipocyte [65] - was one of the
initial motivations behind the present study. Whereas an elegant
series of studies by Jalkanen and co-workers has demonstrated the
role of the endothelial AOC3 in the recruitment and internaliza-
tion of leukocytes during an inflammatory response [13], a similar
primary role for the adipocyte-associated AOC3 has appeared
unlikely. In fact, prior to the present study, the most likely link of
the adipocyte AOC3 to cellular metabolism was an enhancement
of insulin-stimulated glucose uptake [19,21] via an unidentified
pathway.
The approach taken herein has involved a combination of
studies using either human or murine-derived materials. A new
expression system for human AOC3 has been developed that
involves the removal of the 27 amino acid N-terminal transmem-
brane domain and expression in s2 Drosophila cells. Pure protein is
obtained without using peptide-tagged enzyme or reliance on
proprietary monoclonal antibody (Fig. 1), with a yield that is
optimally ca. 0.5 mg/L. Better enzyme yields likely was deterred
by unmatched codon bias between a human-encoded mRNA and
insect-optimized translational machinery [66]. However, it is
possible that future optimization of expression conditions may
increase this yield significantly, given previously demonstrated
examples of quite high level expression of human gene products in
s2 cells [37]. We note that insect cell expression will likely result in
a different pattern of AOC3 post-translational surface glycosyla-
tions, which has been shown to affect catalytic activity [67] and
could impact some of our kinetic measurements of human AOC3.
A second goal for the future will be to enhance the fraction of
expressed AOC3 that contains its post-translationally generated
cofactor, TPQ, which is currently at only 6% of total protein.
Application of a similar expression system for the murine AOC3
has allowed a comparison of kinetic parameters at pH 7.4, 37uC
(Table 3). While the kinetic results indicate a similarity between
the murine and human AOC3 (Table 3), the use of mouse models
in clinical studies aimed at moderating AOC3 activity may be
fraught, especially given expected species differences in tissue levels
of AOC3 substrates (see below).
Currently, the endogenous substrate(s) of AOC3 is/are
unknown, including AOC3 in the endothelial context. Knowing
the endogenous substrate(s) would provide an invaluable clue to
the function of AOC3. However, this endeavor has many
difficulties ranging from the measurement of potentially localized
and low-level concentrations of primary amines in vivo to the
likelihood of different substrates for AOC3 depending on tissue
and even cell type. With this in mind, we decided to take a more
general approach by generating a substrate kinetic profile based on
the purified human enzyme that includes amine substrates found
in the Human Metabolome database, a repository of in vivo
metabolites. These studies, thus, provide the identity of possible
endogenous substrates for future investigation. In addition, almost
all previous kinetic measurements of AOC3 either utilized whole
cell or crude membrane lysates in varying contexts, making
comparison of results difficult. Finally, our approach employs an
oxygen electrode to measure enzyme rate, and is more sensitive
than the commonly used hydrogen peroxide probe, Amplex Red,
which is sensitive to both photo- and hyper-oxidation. A number
of molecular results have emerged regarding the properties of
isolated human AOC3 enzyme that include a low Km value for
O2, in the range expected for O2 levels in the interstitial space of
human tissue, as well as rate limitation by the chemical step of C–
H abstraction under conditions of steady-state turnover of amines
at concentrations below their Km values. The fact that chemistry is
rate-determining for kcat/Km of substrate is a fairly generic
property for all characterized CAOs, and may be reflective of the
relatively low turnover numbers of these enzymes and their ability
to act on a wide series of substrates [3]. The broad range of
substrate specificity is apparent for AOC3, with both aliphatic and
aromatic substrates showing turnover rates of 10
2 to
10
4 M
21 sec
21, following normalization of the enzyme concen-
tration to the number of moles of TPQ per subunit (Table 2). This
lack of specificity is completely consistent with the previously
published active site structure of the human AOC3 [34,35,36]
(Fig. S2) which shows a greatly expanded active site in relation to,
for example, a CAO isozyme from Hansenula polymorpha that acts
with high preference on small substrates such as methylamine
[68]. Although some kinetic differences between the human and
murine AOC3s are detected (Table 3), a pattern of activity on both
aliphatic and aromatic amines is maintained. We note the 10-fold
larger rate for the human than murine forms of enzyme is for
oxidation of methylamine and aminoacetone, two primary amines
shown to be present in human tissue [69]. While several
endogenous pathways for the production of methylamine are
known in humans [45,70], the pathway for aminoacetone
production is less clear. Aminoacetone is generally formed
predominantly via a threonine dehydrogenase (TDH)-supported
oxidation/decarboxylation of threonine [71]; however, the open
reading frame for TDH in humans has been identified as an inactive pseudo-
gene [72], in contrast to the retention of an active TDH in other
mammals [73,74], as well as bacteria [75]. In addition to
aminoacetone and methylamine, other high kcat/Km substrates
warrant further investigation, namely dopamine and cysteamine.
Neurons may be possible sources of dopamine since it is known
that adipose tissue is innervated [76]. As mentioned previously,
adipocytes are sensitive to dopamine through the b3-adrenore-
Table 4. Comparison of AOC3 Km values determined by steady state kinetic studies of purified murine enzyme and whole cell 3T3-
L1 adipocytes.
Substrate Murine3T3 cells (uM) Purified murine AOC3 (uM) Purified human AOC3 (uM)
Methylamine 513
b 800 652
Aminoacetone 35
b 150 66
Isoamylamine 432
a 150 4560
aKm value calculated by plotting endpoint rates vs. substrate concentration, correcting for baseline Amplex Red oxidation by adipocytes pre-treated with 1 mM
semicarbazide for 30 min.
bKm values are averages derived from both endpoint fluorescence versus substrate concentration and linear rates of Amplex Red oxidation versus substrate
concentration.
doi:10.1371/journal.pone.0029270.t004
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cysteamine is involved in the production of coenzyme A, an
integral component of fatty acid breakdown and synthesis. From
these kinetic studies, it is possible that AOC3 could have a novel
regulatory role in both fatty acid metabolism and insulin signaling.
The murine 3T3-L1 cell line has enabled us to compare the
properties of cell-associated AOC3 to that of purified enzyme.
Given the ectopic property of the active site of cell-associated
AOC3, the turnover of amines can be studied relatively easily via
the detection of the extracellular peroxide produced in response to
addition of primary amines. Mature adipocytes show uniform
distribution across the plasma membrane of adipocytes (Fig. 3) and
generate a linear production of hydrogen peroxide over a period of
30 min. The data in Table 4 show a reasonable agreement among
Km values determined using either whole cells or purified
enzymes.
One of the surprising findings from this work is the
demonstration that AOC3 catalyzes the oxidation of amines that
are not produced at significant levels by human tissue: these
include the branched chain aliphatic amines and aminoacetone.
With regard to the former, high levels of isoamylamine
accumulation (3.9 mM versus Km of 4.5 mM for human AOC3)
have been demonstrated in the media from overnight cultures of
Proteus morganii, a human bacterial pathogen [77]. Other human
pathogens that include Bacteroides fragilis, Salmonella typhimurium,
Yersinia entercolitica, Escherichia coli, and Clostridium perfringens [78,79]
are also known to secrete branched chained amines, as well as
small aliphatic amines (up to 2.3 mM n-propylamine and 250 uM
n-butylamine). Thus, another possible role for the adipocyte-
associated AOC3 is the detection of colonizing bacteria via their
production of branched chain amines and aminoacetone. The
production of H2O2 by bacterial-exposed adipocytes would be
capable of impeding bacterial growth directly or possibly via the
recruitment of immune cells. The location and stationary nature of
adipocytes in subcutaneous tissue, which is often one of the first
tissues infected after a wound [80] could rationalize the presence
of an enzymatic reaction that works in concert with immune cells
to minimize local proliferation of bacteria.
In closing, we also comment on a possible link of the adipocyte-
associated AOC3 to the clinical symptoms of obesity [81], noting
that there are several routes that could increase AOC3 activity,
leading to an accompanying inflamed state. These include a
possible change in gut-associated bacteria toward strains produc-
ing aliphatic amines [82], together with the lipid overload
expected to accompany obesity and/or the increased availability
of acetyl CoA seen in diabetes [83]. The latter states could
enhance aminoacetone production via the condensation of acetyl
CoA with glycine to produce 2-amino 3-ketobutyrate [84], Fig. 4.
Although glycine C-acetyl transferase normally works in concert
with TDH to reduce 2-amino 3-ketobutyrate to threonine in many
microorganisms and animals [71], the absence of a functional
TDH in humans [72] would exacerbate the accumulation of the
immediate product, 2-amino 3-ketobutyrate [85], and its break-
down product (aminoacetone) in obese patients. The resulting
turnover of aminacetone by AOC3, and the accompanying
production of hydrogen peroxide, may then function as one of
the triggers for the high macrophage recruitment and inflamma-
tion that occurs in obese adipose tissue.
Supporting Information
Figure S1 Alignment using MultAlin with identical
amino acids in black and differences in red. The murine
enzyme is 83% identical and 91% similar to the human form.
TPQ results from a post-translational modification at Y471.
(TIFF)
Figure S2 Connolly surface comparison of amine oxi-
dase active sites. Comparison of size of active site ‘‘funnels’’ for
substrate binding to the human AOC3 (A) and to a well-
established methylamine oxidase from H. polymorpha (B) and Active
site copper bound to its histidine ligands can be visualized at the
bottom of each figure as a frame of reference. The cofactor to
which substrate binds is immediately above the copper site.
(TIF)
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